2024/11/27 18:40:44 | |
---|---|
Price | |
34.655 USD | |
Difference | 7.76% (2.50) |
ISIN | DE0005785604 |
Symbol | FRE |
Exchange | FINRA other OTC Issues |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 18,964 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 34.655 USD |
High | 34.655 USD |
Low | 34.655 USD |
Close (prev. day) | 32.16 USD |
VWAP | 34.655 USD |
Volume (pcs) | 150 |
Trading volume | 5,198.25 |
Number of trades | 1 |
Last size | 150 |
Related Futures | 53 |
Related Options | - |
Date | Headline | Download | |
2022/05/04 | Global Equity Ratings | ||
2022/04/27 | Global Equity Ratings | ||
2022/04/14 | Global Equity Ratings | ||
2022/03/29 | Global Equity Ratings | ||
2022/03/10 | Global Equity Ratings |
2024/11/27 18:40:44 | |
---|---|
Price | |
34.655 USD | |
Difference | 7.76% (2.50) |
ISIN | DE0005785604 |
Symbol | FRE |
Exchange | FINRA other OTC Issues |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 18,964 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 34.655 USD |
High | 34.655 USD |
Low | 34.655 USD |
Close (prev. day) | 32.16 USD |
VWAP | 34.655 USD |
Volume (pcs) | 150 |
Trading volume | 5,198.25 |
Number of trades | 1 |
Last size | 150 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.52 | 0.52 | 0.71 |
Volatility | 49.05 | 57.82 | 39.90 |
Ø price 5 days | Ø volume 5 days (pcs.) | - USD (3,015) |
Ø price 30 days | Ø volume 30 days (pcs.) | 34.518 USD (658) |
Ø price 100 days | Ø volume 100 days (pcs.) | 34.947 USD (475) |
Ø price 250 days | Ø volume 250 days (pcs.) | 30.685 USD (564) |
YTD High | date | 37.500 USD (2024/10/09) |
YTD Low | date | 26.650 USD (2024/04/19) |
52 Weeks High | date | 37.500 USD (2024/10/09) |
52 Weeks Low | date | 26.650 USD (2024/04/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/12/06 | 17:35 | 33.67 EUR | 25.77 | 1,874 |
Vienna Stock Exchange | 2024/12/06 | 17:32 | 33.70 EUR | 0.00 | 5 |
Tradegate | 2024/12/06 | 22:26 | 33.46 EUR | 1.32 | 186 |
Stuttgart | 2024/12/06 | 21:59 | 33.43 EUR | 0.39 | 194 |
SIX Swiss Exchange | 2023/02/17 | 17:35 | 29.00 EUR | 0.00 | 1 |
SIX Swiss Exchange | 2020/04/01 | 05:55 | 53.06 CHF | 0.00 | 1 |
Munich | 2024/12/06 | 17:26 | 33.66 EUR | 0.02 | 4 |
Hanover | 2024/12/06 | 08:16 | 33.78 EUR | 0.00 | 1 |
Hamburg | 2024/12/06 | 14:23 | 33.74 EUR | 0.01 | 4 |
Frankfurt | 2024/12/06 | 17:34 | 33.55 EUR | 0.35 | 8 |
FINRA other OTC Issues | 2024/11/27 | 18:40 | 34.655 USD | 0.01 | 1 |
Euronext Milan MTF Trading After Hours | 2024/10/15 | 18:39 | 32.76 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/12/06 | 17:44 | 33.69 EUR | 0.00 | 1 |
Duesseldorf | 2024/12/06 | 19:31 | 33.45 EUR | 0.00 | 7 |
Berlin | 2024/12/06 | 21:52 | 33.53 EUR | 0.01 | 17 |
FRESENIUS SE & CO. KGAA |
- - |
Else-Kröner-Strasse 1 - 61352 Bad Homburg |
Telefon: +49-6172-608-0 |
Fax: +49-6172-608-2628 |
E-mail: pr-fre@fresenius.com |
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany. |
Michael Sen | Chairman of Managing Board |
Michael Moser | Member of Executive Committee |
Pierluigi Antonelli | Member of Executive Committee |
Robert Möller | Member of Executive Committee |
Sara Lisa Hennicken | Member of Executive Committee |
Wolfgang Kirsch | Chairman of Supervisory Board |
Christoph Zindel | Member of Supervisory Board |
Iris Löw-Friedrich | Member of Supervisory Board |
Michael Albrecht | Member of Supervisory Board |
Bernd Behlert | Member of Supervisory Board |
Frauke Lehmann | Member of Supervisory Board |
Grit Genster | Member of Supervisory Board |
Holger Michel | Member of Supervisory Board |
Konrad Kölbl | Member of Supervisory Board |
Michael Diekmann | Member of Supervisory Board |
Oscar Romero de Paco | Member of Supervisory Board |
Susanne Zeidler | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.
The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.